CHARLES SCHWAB INVESTMENT MANAGEMENT INC - RENEO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$285,585
+47.3%
37,503
+26.9%
0.00%
Q2 2023$193,861
+246.2%
29,552
+56.9%
0.00%
Q1 2022$56,000
-65.2%
18,8300.0%0.00%
Q4 2021$161,000
+61.0%
18,830
+40.8%
0.00%
Q3 2021$100,000
-20.0%
13,3710.0%0.00%
Q2 2021$125,00013,3710.00%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Abingworth LLP 1,962,221$18,190,0005.62%
RiverVest Venture Management LLC 2,409,220$22,478,0004.39%
Novo Holdings A/S 3,430,377$32,005,0001.42%
Aisling Capital Management LP 886,075$8,267,0001.32%
NEA Management Company, LLC 4,786,921$44,662,0000.58%
Prosight Management, LP 54,934$513,0000.32%
Rock Springs Capital Management LP 1,129,024$10,534,0000.21%
Pinz Capital Management, LP 56,823$530,0000.16%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 750,000$6,998,0000.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 849,300$7,924,0000.14%
View complete list of RENEO PHARMACEUTICALS INC shareholders